The vector of anti-MART-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MART-1. The T cells are genetically modified through transduction with a retroviral vector expressing MART-1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-WFY2279||Anti-MLANA (CBFYM-2273) h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-TCR-C293||Lenti-MART-1 T cell receptor (Codon optimized) (DMF4) Viral Particle|
|CAR-T-2-M310-BZ||Anti-MART-1(DMF5) scFv h(41BB-CD3ζ) CART, pCDCAR1|
|VP-TCR-C300||Lenti-melan-A T cell receptor (SW-M1-29) Viral Particle|
|CAR-WFY2268||Anti-MLANA (CBFYM-0343) h(41BB-CD3ζ) CAR, pCDCAR1|
|TCR-C141Z||Human anti-MART1 T cell receptor (1D3), pCDTCR1|
|VP-CAR-LC331||Lenti-MART-1(DMF5) CAR (scFv-CD3ζ, Melan-A) Viral Particle|
|TCR-L067||Murinized (from Human) anti-MLANA (ELAGIGILTV) T Cell Receptor, pMSGV1|
|DMAb-2271-FY||Mouse Anti-MLANA DNA-encoded mAb (CBFYM-0427), pVAX1|
|CAR-YF008||Anti-MART-1 (M7) h(CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved